| HOME >> BIOLOGY >> TECHNOLOGY |
For more information, please contact:
Integrated Corporate Relations, Inc.
Ashley M. Ammon
Tel: +1-646-277-1200
AMERICAN ORIENTAL BIOENGINEERING, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME AND
COMPREHENSIVE INCOME
THREE MONTHS ENDED YEAR ENDED
DECEMBER 31, DECEMBER 31,
2009 2008 2009 2008
Revenues $100,032,887 $96,270,506 $296,150,780 $264,643,058
Cost of sales 47,425,009 36,222,784 129,367,775 91,031,274
GROSS PROFIT 52,607,878 60,047,722 166,783,005 173,611,784
Selling and
marketing expenses 14,142,993 17,117,853 40,996,370 39,774,330
Advertising costs 9,536,612 12,342,238 31,896,992 34,102,538
Research and
development costs 6,652,704 602,868 7,922,357 1,528,991
General and
administrative
expenses 6,457,024 4,765,273 21,168,566 18,074,956
Depreciation and
amortization
expenses 920,037 1,371,108 6,038,625 4,383,215
Purchased in-
process research
and development
expenses -- 12,255,248 -- 12,255,248
Total operating
expenses 37,709,370 48,454,588 108,022,910 110,119,278
INCOME FROM
OPERATIONS 14,898,508 11,593,134 58,760,095 63,492,506
Equity in earnings
(loss) from
unconsolidated
entities 2,374,211 (542,395) 2,075,139 (1,132,986)
Interest income
(expense), net (1,440,239) (1,414,233) (5,746,382) (2,571,015)
'/>"/>
| SOURCE American Oriental Bioengineering, Inc. Copyright©2010 PR Newswire. All rights reserved |